Description
This session presents groundbreaking insights into advancing personalized treatment strategies in psychiatry through three distinct talks. Dr. Marmar highlights the substantial causal benefits of treatment with Gabapentine Enacarbil Extended-Release (GE-XR) for a specific subset of patients predicted to be likely responders. The talk emphasizes the innovative likely responder statistical paradigm as a promising approach for analyzing randomized clinical trials, contributing to the evolution of personalized treatment methodologies. Shifting focus to the realm of alcohol use disorder (AUD), Dr. Sugarman explores the potential of digital interventions to overcome barriers to treatment for women with AUD and co-occurring disorders. By offering an accessible and cost-effective alternative to traditional in-person services, digital interventions emerge as a transformative solution. Dr. Sugarman's presentation delves into research on a gender-specific digital intervention tailored to address the unique challenges faced by women in their journey towards recovery. In the field of addiction psychiatry, Dr. Diaz Granados introduces the concept of precision medicine as a valuable tool for identifying dysfunctional domains that can be targeted in treatment. The Addiction Neuroclinical Assessment, evaluating incentive salience, negative emotionality, and executive functioning, becomes a pivotal framework. Driven by an understanding of individual variations in these domains, the presentation proposes tailoring interventions based on patients' specific functional or dysfunctional profiles, paving the way for more effective and personalized addiction treatments. Collectively, these talks contribute to a comprehensive understanding of personalized treatment in psychiatry, incorporating innovative statistical paradigms, digital interventions, and precision medicine. This session not only highlights the current advancements but also sets the stage for future breakthroughs in individualized psychiatric care.
Format
Recorded webinar.
This content was recorded during the APA 2024 Annual Meeting.
Learning Objectives
- Understand the substantial causal benefits of treatment with GE-XR for a subset of patients predicted to be likely responders.
- As a result of attending this presentation, participants will be able to recognize how digital interventions can be integrated into treatment to address the needs of women with alcohol use disorder.
- Understand the diversity under the Alcohol Use Disorder diagnosis and be able to identify different areas of assessment that might aid in patient treatment.
Target Audience
Residents/Fellows, Psychiatrists, Psychologists
Estimate Time to Complete
Estimated Duration: 1.5 hours
Program Start Date: May 17, 2025
Program End Date: May 17, 2028
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™ may do so after completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.
Continuing Education Credit
In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The APA designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Instructors
- Charles Marmar, MD.
- Dawn Sugarman, MD.
- Nancy Diazgranados, MD, MS, DFAPA.
Planners
- Vishal Madaan, MD, Chief of Education and Deputy Medical Director at the American Psychiatric Association.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) business days prior to the start of a live webinar.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
- The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
- Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
- Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
- Internet Connection: 1 Mbps or higher
Minimum Requirements:
- Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
- Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance